Literature DB >> 31045233

Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic Dermatitis.

Takahito Chiba1, Takuya Nagai, Shin-Ichi Osada, Motomu Manabe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31045233     DOI: 10.2340/00015555-3208

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  5 in total

Review 1.  Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis.

Authors:  Kumi Nakazaki; Mina Yoshida; Yosuke Masamoto; Aya Shinozaki-Ushiku; Masako Ikemura; Teruyoshi Hisamoto; Megumi Yasunaga; Shinichi Sato; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2022-03-30       Impact factor: 2.319

2.  Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas.

Authors:  Ingrid Lazaridou; Caroline Ram-Wolff; Jean-David Bouaziz; Edouard Bégon; Maxime Battistella; Jacqueline Rivet; Marie Jachiet; Martine Bagot; Adèle de Masson
Journal:  Acta Derm Venereol       Date:  2020-09-30       Impact factor: 3.875

Review 3.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30

4.  Mass Cytometric Analysis of Early-Stage Mycosis Fungoides.

Authors:  Nannan Guo; Li Jia; Coby Out-Luiting; Noel F C C de Miranda; Rein Willemze; Frits Koning; Maarten Vermeer; Koen Quint
Journal:  Cells       Date:  2022-03-22       Impact factor: 6.600

Review 5.  Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas.

Authors:  Karol Kołkowski; Magdalena Trzeciak; Małgorzata Sokołowska-Wojdyło
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.